FDA campaign H-0097-2026
Class IIHazard
Possible presence of stones in product
Distribution
WI, TX, MI, IL, NC, GA, LA, CA, NJ
REKALLD area-alert coverage: CA, GA, IL, LA, MI, NC, NJ, TX, WI (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.